Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Juluca (Dolutegravir and Rilpivirine) for the Treatment of HIV-1 Infection

Drug (Brand / Generic)

Juluca / Dolutegravir and Rilpivirine

Developed by

ViiV Healthcare

Therapy Class

Integrase strand transfer and non-nucleoside reverse transcriptase inhibitors

Current Indication

HIV-1 infection

Market Sector

Anti-infective

Development Status

Approved in the US
Expand

Go Top